Professor Ian Frazer AC
Deputy Chairman of the Board, Chair of Medical Advisory Board
Our leadership team
Powering innovation in medical care through our precision microbiome science
Microba’s precise microbiome analysis is built on the expertise of our innovative team at the leading edge of microbiome science
Driven to discover
Our approach to microbiome analysis is enabling new discoveries and advancing the understanding of the microbiome in health and disease.
At Microba Life Sciences, we believe comprehensive and precise measurement of the human gut microbiome is required to drive innovation in medical care. Through our powerful analysis and discovery platforms, we are identifying novel microbiome-derived therapeutics and new diagnostic tools to advance medicine.
Our growing team is built on a foundation of scientific and technical excellence and a drive to discover ever-deeper insights into the relationships between gut microorganisms and health. We are continually increasing and refining the precision of our analysis, and we believe in working with international partners who share our passion and scientific rigour to fast-track these new advances.
In short, we believe in transforming human health by harnessing the gut microbiome, and we are leading life-changing microbiome discoveries based on ever more precise analysis of the microbiome.
Our innovative team
Professor Gene Tyson
Co-founder, Non-Executive Director
Professor Philip Hugenholtz
Co-founder, Chair of Scientific Advisory Board
Associate Professor Lutz Krause
Chief Scientific Officer
Blake Wills
Chief Executive Officer
Dr Luke Holtham Reid
President
Holly Bauzon
Vice President, Commercial Development
Dr Caroline Popper
Non-Executive Director
Mark Capone
Non-Executive Director
Dr Páraic Ó Cuív
Lead, Live Biotherapeutics
Dr Nicola Angel
Head of Laboratory Operations
Associate Professor Jake Begun
Medical Advisory Board, IBD Advisory Panel
Associate Professor Paul Griffin
Medical Advisory Board
Dr Alena Pribyl
Senior Scientist and Research Officer
Dr Kaylyn Tousignant
Scientific Writer
Pasquale Rombola
Chairman of the Board
Dr Kylie Ellis
Head of Research Partnerships
Mark Parker
Global Business Development
Dr Jean-Philippe Laine
US Director of Business Development
Daniela Sanders
Regulatory Affairs Advisor
Dr David Wood
Head of Bioinformatics Operations
Dr Areej Alsheikh
Bioinformatician
Dr Joel Boyd
Bioinformatician
Bozica Nyeverecz
Quality Manager
Dr Kasra Sabermanesh
Regional Partnerships Manager
Dr Ken McGrath
Clinical Solutions Manager
Tim Dwyer
Product Manager
Hayley Parcell
Head of Insight™
Dr Paula Smith-Brown
Clinical Science Lead
James Heath
Chief Financial Officer and Company Secretary
Richard Bund
Non-Executive Director
Dr Hyungtae Kim
Non-Executive Director
Drew Webb
Chief Marketing Officer
Yao Liu
Chief Technology Officer
Associate Professor Chris Hogan
Medical Advisory Board
Our foundations in microbiome science
Our Co-founders, Professor Gene Tyson and Professor Philip Hugenholtz, are recognised world leaders in their fields who pioneered major advancements in metagenomics and set new standards for the classification of microorganisms.
They have continued to build on their early discoveries, using ever-advancing technology and bioinformatic approaches to reveal more of the microbiome and its relationships to disease conditions. The founders continue to ensure that the highest scientific standards are used throughout the company.
Professor Philip Hugenholtz
Throughout his career as a microbiologist, Professor Hugenholtz has made globally recognised contributions to the field, publishing over 200 papers in respected microbiology and genomics journals and being repeatedly listed on the Web of Science’s Highly Cited Researchers list. He has been instrumental in the development and application of many of the methods used in microbiome analysis, including metagenomic DNA sequencing and the standardisation of bacterial taxonomy. Professor Hugenholtz is a member of the Australian Academy of Sciences and is also Director of the Australian Centre for Ecogenomics (ACE), Australia’s leading centre for microbial genomic research.
Publications
Professor Gene Tyson
As a microbial ecologist, Professor Tyson was the first person to publish the use of metagenomic sequencing to assess microbial communities and to inform the culture of novel microorganisms. These pioneering papers highlighted the potential of metagenomics to provide a high-resolution taxonomic and functional picture of microbial communities. Since then, Professor Tyson has continued to develop many of the tools used in the analysis of metagenomic data and is also repeatedly listed on the Web of Science’s Highly Cited Researchers list. Professor Tyson is leading microbiome research at the Queensland University of Technology.
Publications
Partner with us to turn our precision science into transformative health solutions.
We are determined to drive the innovation of new medical diagnostic tools and treatments through our precision microbiome science. We are always willing to discuss what we can achieve through partnership.
Contact us